`

Evelo Biosciences

Biotechnology Research

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$25.5M
size-icon Size
11 - 50

Frequently Asked Questions About Evelo Biosciences

What does Evelo biosciences do?+

Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAXTM, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Companys first product candidates are pharmaceutical preparations of single strains of microbes selected for their potential to offer defined pharmacological properties. Evelos therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people with inflammatory diseases and cancer. Evelo currently has four product candidates in development: EDP1815, EDP1867, and EDP2939 for the...

What is Evelo biosciences's industry? +

Evelo biosciences operates in the Biotechnology research industry.

What is Evelo biosciences's revenue? +

Evelo biosciences's revenue is 11m - 100m

What is Evelo biosciences's company size? +

Evelo biosciences has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.